Mesoblast (MESO) EBITDA Margin (2015 - 2023)
Mesoblast's EBITDA Margin came in at 222.06% for the year ended Jun 30, 2026, down 316.29 percentage points from 538.34% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) EBITDA Margin (2015 - 2023) Analysis & Trends
Going back to the year ended Jun 30, 2015, Mesoblast's EBITDA Margin data covers 12 years.
- EBITDA Margin carries a five-year change of +1649.01 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 represents the lowest annual EBITDA Margin since the year ended Jun 30, 2022.
- Per Business Quant, earlier years put EBITDA Margin at 538.34% in the year ended Jun 30, 2025 (-736.89 pp), 1275.23% in the year ended Jun 30, 2024 (+50.01 pp), 1225.22% in the year ended Jun 30, 2023 (+2248.57 pp) and -1023.35% in the year ended Jun 30, 2022 (+403.61 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Mesoblast | 1.88 Bn | 1.44 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -2,656.57% |
| Mar 31, 2023 | -1,167.61% |
| Dec 31, 2022 | -1,389.88% |
| Sep 30, 2022 | -1,352.69% |
| Jun 30, 2022 | -2,277.88% |
| Mar 31, 2022 | -1,200.60% |
| Dec 31, 2021 | -1,271.63% |
| Sep 30, 2021 | -703.23% |
| Jun 30, 2021 | -1,242.63% |
| Mar 31, 2021 | -1,501.67% |
| Dec 31, 2020 | -1,143.82% |
| Sep 30, 2020 | -2,082.15% |
| Jun 30, 2020 | -5,585.73% |
| Mar 31, 2020 | -161.35% |
| Dec 31, 2019 | -1,293.25% |
| Sep 30, 2019 | -58.80% |
| Jun 30, 2019 | -1,363.24% |
| Mar 31, 2019 | -2,354.84% |
| Dec 31, 2018 | -1,572.78% |
| Sep 30, 2018 | -191.70% |
API Access
Mesoblast EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();